M1A.2511 Drug-induced chronic gout, right hip, with tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Right Hip, with Tophus (tophi)

Summary

Drug-induced chronic gout, right hip, with tophus (tophi) is a form of arthritis affecting the right hip joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in the affected area.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the right hip joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense right hip pain, often with swelling and redness
• Persistent warmth and tenderness in the affected hip
• Formation of tophi (hard, painless lumps) around the right hip joint
• Stiffness and limited range of motion in the right hip
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis may identify urate crystals. Imaging, such as X-rays or ultrasound, can detect tophi and joint damage. The right hip is specifically assessed for involvement.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs. Tophi may require surgical removal in severe cases. Lifestyle modifications, such as dietary changes, are often recommended.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is essential to monitor uric acid levels and adjust treatment. Untreated cases may lead to progressive joint damage and disability.

Complications

• Chronic joint damage and deformity in the right hip
• Persistent pain and reduced mobility
• Increased risk of kidney stones or renal impairment
• Infection of tophi (rare but serious)

Lifestyle & Prevention

• Avoid medications known to raise uric acid levels when possible
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
• Stay hydrated to support uric acid excretion
• Limit alcohol consumption, especially beer and spirits
• Engage in regular, low-impact exercise to support joint health

When to Seek Professional Help

Seek medical attention if you experience severe or worsening right hip pain, swelling, or stiffness, or if tophi appear or increase in size. Prompt evaluation is important to prevent joint damage and complications.

Tips for Medical Coders

This code (M1A.2511) specifies drug-induced chronic gout affecting the right hip with tophus. Documentation should clearly indicate the right hip involvement, the presence of tophi, and the drug-induced etiology. Ensure clinical notes support the anatomic site and the presence of tophi to justify code assignment.